There have been 50 recent insider transactions recorded for NGM Biopharmaceuticals, Inc. (NGM), including 26 buys and 24 sells. Total insider buying was valued at $5.19M and total insider selling at $20.6M.
Notable insiders with recent activity include Goeddel David V, Rieflin William Jl, Perlmutter Roger M. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NGM
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-04-05 |
Goeddel David V |
10 Percent Owner |
Return of Shares |
16,806 |
$20.37 |
$342.34K |
- |
| 2024-04-05 |
Rieflin William Jl |
Director |
Return of Shares |
225,000 |
$8.14 |
$1.83M |
- |
| 2024-04-05 |
Perlmutter Roger M |
Director |
Return of Shares |
24,222 |
$13.35 |
$323.36K |
- |
| 2024-04-05 |
Column Group L P |
10 Percent Owner |
Return of Shares |
44,000 |
- |
- |
- |
| 2024-04-05 |
Pierce Valerie L |
See Remarks |
Return of Shares |
147,000 |
$4.36 |
$640.92K |
- |
| 2024-04-05 |
Viret Jean-frederic |
Chief Financial Officer |
Return of Shares |
450,000 |
$0.77 |
$346.5K |
- |
| 2024-04-05 |
Lieu Hsiao D |
Chief Medical Officer |
Return of Shares |
159,000 |
$4.36 |
$693.24K |
- |
| 2024-04-05 |
Hooper Suzanne Sawochka |
Director |
Return of Shares |
25,000 |
$12.06 |
$301.5K |
- |
| 2024-04-05 |
Guyer Shelly D |
Director |
Return of Shares |
16,806 |
$20.37 |
$342.34K |
- |
| 2024-04-05 |
Column Group Gp, Lp |
10 Percent Owner |
Return of Shares |
44,000 |
- |
- |
- |
| 2024-04-05 |
Woodhouse David J |
Chief Executive Officer |
Return of Shares |
500,000 |
$4.36 |
$2.18M |
- |
| 2024-04-05 |
Ho Carole |
Director |
Return of Shares |
39,515 |
$20.66 |
$816.38K |
- |
| 2024-04-05 |
Tcg Opportunity Iii Gp, Llc |
10 Percent Owner |
Return of Shares |
44,000 |
- |
- |
- |
| 2024-04-05 |
Perlich Irene |
Principal Accounting Officer |
Return of Shares |
20,000 |
$1.07 |
$21.4K |
- |
| 2024-01-16 |
Pierce Valerie L |
SVP, Gc & Cco |
Tax Withholding of RSU |
5,021 |
$1.34 |
$6.73K |
55,374 |
| 2024-01-16 |
Lieu Hsiao D |
EVP, Chief Medical Officer |
Tax Withholding of RSU |
5,430 |
$1.34 |
$7.28K |
54,254 |
| 2024-01-16 |
Woodhouse David J |
Chief Executive Officer |
Tax Withholding of RSU |
13,032 |
$1.34 |
$17.46K |
131,822 |
| 2024-01-16 |
Perlich Irene |
Principal Accounting Officer |
Tax Withholding of RSU |
1,025 |
$1.34 |
$1.37K |
8,975 |
| 2023-12-01 |
Viret Jean-frederic |
Chief Financial Officer |
RSU Award |
450,000 |
$0.77 |
$346.5K |
450,000 |
| 2023-11-16 |
Goeddel David V |
10 Percent Owner |
Informative Buy |
1,460 |
$0.62 |
$906.81 |
134,180 |
| 2023-11-16 |
Column Group L P |
10 Percent Owner |
Informative Buy |
5,840 |
$0.62 |
$3.63K |
949,862 |
| 2023-11-15 |
Goeddel David V |
10 Percent Owner |
Informative Buy |
2,720 |
$0.71 |
$1.92K |
132,720 |
| 2023-11-15 |
Column Group L P |
10 Percent Owner |
Informative Buy |
16,791 |
$0.71 |
$11.88K |
944,022 |
| 2023-11-06 |
Pierce Valerie L |
SVP, Gc & Cco |
Return of Shares |
150,000 |
$15.20 |
$2.28M |
- |
| 2023-11-06 |
Lieu Hsiao D |
EVP, Chief Medical Officer |
Return of Shares |
100,000 |
$31.93 |
$3.19M |
- |
| 2023-11-06 |
Woodhouse David J |
Chief Executive Officer |
Return of Shares |
400,000 |
$16.47 |
$6.59M |
- |
| 2023-11-06 |
Perlich Irene |
Principal Accounting Officer |
Return of Shares |
35,000 |
$15.20 |
$532K |
- |
| 2023-11-03 |
Viret Jean-frederic |
Chief Financial Officer |
Disposition |
- |
- |
- |
38 |
| 2023-09-15 |
Perlich Irene |
Principal Accounting Officer |
Disposition |
30,000 |
$4.36 |
$130.8K |
- |
| 2023-05-10 |
Goeddel David V |
10 Percent Owner |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Rieflin William Jl |
Director |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Perlmutter Roger M |
Director |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Hooper Suzanne Sawochka |
Director |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Guyer Shelly D |
Director |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-05-10 |
Ho Carole |
Director |
RSU Award |
78,407 |
$3.69 |
$289.32K |
78,407 |
| 2023-03-02 |
Pierce Valerie L |
SVP, Gc & Cco |
RSU Award |
49,000 |
- |
- |
55,667 |
| 2023-03-02 |
Lieu Hsiao D |
SVP, Chief Medical Officer |
RSU Award |
53,000 |
- |
- |
55,605 |
| 2023-03-02 |
Woodhouse David J |
Chief Executive Officer |
RSU Award |
127,200 |
- |
- |
144,854 |
| 2023-03-02 |
Chen Jin-long |
Chief Scientific Officer |
RSU Award |
175,000 |
$4.36 |
$763K |
175,000 |
| 2023-03-02 |
Nolan Mangini Siobhan |
President and CFO |
RSU Award |
76,000 |
- |
- |
76,000 |
| 2023-01-31 |
Goeddel David V |
10 Percent Owner |
Informative Buy |
176,730 |
$5.00 |
$883.4K |
927,231 |
| 2023-01-31 |
Column Group L P |
10 Percent Owner |
Informative Buy |
176,730 |
$5.00 |
$883.4K |
927,231 |
| 2023-01-30 |
Goeddel David V |
10 Percent Owner |
Informative Buy |
7,542 |
$5.00 |
$37.71K |
750,501 |
| 2023-01-30 |
Column Group L P |
10 Percent Owner |
Informative Buy |
7,542 |
$5.00 |
$37.71K |
750,501 |
| 2023-01-23 |
Goeddel David V |
Director |
Informative Buy |
9,900 |
$5.00 |
$49.49K |
742,959 |
| 2023-01-23 |
Column Group L P |
Director |
Informative Buy |
9,900 |
$5.00 |
$49.49K |
742,959 |
| 2023-01-20 |
Goeddel David V |
Director |
Informative Buy |
500 |
$5.00 |
$2.5K |
733,059 |
| 2023-01-20 |
Column Group L P |
Director |
Informative Buy |
500 |
$5.00 |
$2.5K |
733,059 |
| 2023-01-19 |
Goeddel David V |
Director |
Informative Buy |
37,639 |
$5.00 |
$188.1K |
732,559 |
| 2023-01-19 |
Column Group L P |
Director |
Informative Buy |
37,639 |
$5.00 |
$188.1K |
732,559 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry